Bixiye
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021
Natiijooyinka Raadinta
Soo bandhiga 2451 - 2460 ee natiijooyinka 4128
Bixiye
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
P29-21 Reimbursement Change for Licensed Professional Clinical Counselors (LPCC)
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P21-21 RAP Claims Required for Home Care Claims Effective July 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P26-21 Sequestration Suspension for Medicare Lines of Business Extended
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P32-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Musculoskeletal Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P22-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P27-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 5, 2021
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021